According to our latest research, the global atrial septal defect market size reached USD 1.38 billion in 2024, driven by a strong demand for advanced cardiac care and rising awareness about congenital heart diseases. The market is experiencing a robust compound annual growth rate (CAGR) of 7.1% and is forecasted to reach USD 2.57 billion by 2033. This growth is primarily attributed to technological advancements in minimally invasive procedures, increasing prevalence of congenital heart anomalies, and expanding healthcare infrastructure worldwide. The marketÂ’s positive trajectory is further underpinned by enhanced screening programs and the introduction of innovative device closure techniques, as per our most recent analysis. https://growthmarketreports.com/report/atrial-septal-defect-market-global-industry-analysis